Actinium Pharmaceuticals
ATNM
ATNM
27 hedge funds and large institutions have $5.66M invested in Actinium Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
10% less funds holding
Funds holding: 30 → 27 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
27
Holding in Top 10
–
Calls
$182K
Puts
$29K
Top Buyers
| 1 | +$450K | |
| 2 | +$247K | |
| 3 | +$83.4K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$43.4K |
| 5 |
Morgan Stanley
New York
|
+$32.4K |
Top Sellers
| 1 | -$51K | |
| 2 | -$39K | |
| 3 | -$24K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.2K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$5K |